https://tonic.inserm.fr/wp-content/uploads/2019/09/Laure-Saint-Aubert-150x150.jpg
 

Laure SAINT-AUBERT

POST-DOCTORANTE

    Abstracts rédigés ou co-rédigés

  • > Amyloid imaging in cerebral amyloid angiopathy –related intracerebral haemorrhage and Alzheimer’s disease: a voxel-wise approach.

    Mélanie PLANTON, Laure Saint-Aubert, Nicolas Raposo, Pierre Payoux, Jean-Francois Albucher, Jean Marc Olivot, Patrice Péran, and Jérémie Pariente

    5th Congress of the European Academy of Neurology, EAN 2019, 29 juin- 2 Juillet 2019 à Oslo, Norvège.
  • > Correlation between glucose metabolism and visual complaint in posterior cortical atrophy. A FGD-PET study.

    Guerrier L., Cransac C., Pagès B., Saint-Aubert L., Péran P., Pariente J.

    Réunion Francophone sur la Maladie d’Alzheimer & les Syndrome Apparentés (RFMASA). 11-14 Juin 2018, Lille, France.

    Publications rédigées ou co-rédigées

  • > 21- Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study.

    Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.

    Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12069.
  • > 1- Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study.

    Planton M, Saint-Aubert L, Raposo N, Payoux P, Salabert AS, Albucher JF, Olivot JM, Péran P, Pariente J.

    J Alzheimers Dis. 2020 Jan 13. doi: 10.3233/JAD-190625.
  • > 51- Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study

    Guerrier L, Cransac C, Pages B, Saint-Aubert L, Payoux P, Péran P, Pariente J

    Front Neurol. 2019 Sep 20;10:1010. doi: 10.3389/fneur.2019.01010.
  • > 38- Cognitive changes of older adults with an equivocal amyloid load.

    Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.

    J Neurol. 2019 Apr;266(4):835-843. doi: 10.1007/s00415-019-09203-5. Epub 2019 Jan 28.
  • > 64- Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease.

    Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K, Nordberg A.

    Eur J Nucl Med Mol Imaging. 2019 May;46(5):1152-1163. doi: 10.1007/s00259-018-4242-6. Epub 2019 Jan 4.
  • > 4- Cognitive changes of older adults with an equivocal amyloid load.

    Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.

    J Neurol. 2019 Jan 28. doi: 10.1007/s00415-019-09203-5.
  • > 22- Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.

    Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C.

    Alzheimers Res Ther. 2018 May 10;10(1):45. doi: 10.1186/s13195-018-0374-y.
  • > 27- High prevalence of cognitive impairment after intracerebral hemorrhage.

    Planton M, Saint-Aubert L, Raposo N, Branchu L, Lyoubi A, Bonneville F, Albucher JF, Olivot JM, Péran P, Pariente J.

    PLoS One. 2017 Jun 1;12(6):e0178886. doi: 10.1371/journal.pone.0178886. eCollection 2017.
  • > 39- Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage.

    Eustache P, Nemmi F, Saint-Aubert L, Pariente J, Péran P.

    J Alzheimers Dis. 2016;50(4):1035-50. doi: 10.3233/JAD-150353.
  • > 36- Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer’s Disease.

    Pistono A, Jucla M, Barbeau EJ, Saint-Aubert L, Lemesle B, Calvet B, Köpke B, Puel M, Pariente J.

    J Alzheimers Dis. 2016;50(3):687-98. doi: 10.3233/JAD-150408.
  • > 51- Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.

    Saint-Aubert L, Pariente J, Dumas H, Payoux P, Brandel JP, Puel M, Vital A, Guedj E, Lesage S, Peoc’h K, Brefel Courbon C, Ory Magne F.

    BMC Neurol. 2016 Jul 30;16:122. doi: 10.1186/s12883-016-0643-y.
  • > White matter disruption at the prodromal stage of Alzheimer’s disease: relationships with hippocampal atrophy and episodic memory performance.

    Rémy F, Vayssière N, Saint-Aubert L, Barbeau E, Pariente J.

    Neuroimage Clin. 2015 Jan 27;7:482-92. doi: 10.1016/j.nicl.2015.01.014.
  • > A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.

    Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J.

    J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222.
  • > Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects.

    Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.

    Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4.
  • > Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.

    Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.

    Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8.